Results 241 to 250 of about 274,980 (287)
Some of the next articles are maybe not open access.
Mergent's Dividend Achievers, 2006
AbstractPharmaceuticals (MIC: 9.1 SIC: 2834 NAIC: 325412)Pfizer is a research‐based, global pharmaceutical company that discovers, develops, manufactures and markets medicines for humans and animals as well as consumer healthcare products. The products include Norvasc, for the treatment of hypertension and angina, Zyrtec, an anti‐allergy medicine ...
+4 more sources
AbstractPharmaceuticals (MIC: 9.1 SIC: 2834 NAIC: 325412)Pfizer is a research‐based, global pharmaceutical company that discovers, develops, manufactures and markets medicines for humans and animals as well as consumer healthcare products. The products include Norvasc, for the treatment of hypertension and angina, Zyrtec, an anti‐allergy medicine ...
+4 more sources
Mergent's Dividend Achievers, 2008
AbstractPharmaceuticals (MIC: 9.1 SIC: 2834 NAIC: 325412)Pfizer discovers, develops, produces and markets prescription medicines for humans and animals. Co. has two key segments: Pharmaceutical, which develops and produces products that treat cardiovascular and metabolic diseases, central nervous system disorders, arthritis and pain, infectious and ...
openaire +2 more sources
AbstractPharmaceuticals (MIC: 9.1 SIC: 2834 NAIC: 325412)Pfizer discovers, develops, produces and markets prescription medicines for humans and animals. Co. has two key segments: Pharmaceutical, which develops and produces products that treat cardiovascular and metabolic diseases, central nervous system disorders, arthritis and pain, infectious and ...
openaire +2 more sources
IDrugs : the investigational drugs journal, 1999
Voriconazole is undergoing phase III trials by Pfizer as a potential treatment for resistant systemic aspergillosis, candidosis and other emerging fungal infections seen in immunocompromised patients [201603,320737]. The compound demonstrated efficacy in patients in whom amphotericin had failed to control infection [167646].
Verweij, P.E. +2 more
openaire +2 more sources
Voriconazole is undergoing phase III trials by Pfizer as a potential treatment for resistant systemic aspergillosis, candidosis and other emerging fungal infections seen in immunocompromised patients [201603,320737]. The compound demonstrated efficacy in patients in whom amphotericin had failed to control infection [167646].
Verweij, P.E. +2 more
openaire +2 more sources
Ethical Human Psychology and Psychiatry, 2005
Against a background of longstanding concerns that antidepressants may trigger suicidality, the Food and Drug Administration (FDA) in 2004 convened two committees to review the issues. Prior to the second meeting Pfizer posted an extensive ad hominem attack on me on FDA’s website. There was no opportunity to post a response.
openaire +1 more source
Against a background of longstanding concerns that antidepressants may trigger suicidality, the Food and Drug Administration (FDA) in 2004 convened two committees to review the issues. Prior to the second meeting Pfizer posted an extensive ad hominem attack on me on FDA’s website. There was no opportunity to post a response.
openaire +1 more source
Mergent's Dividend Achievers, 2005
AbstractPharmaceuticals (MIC: 9.1 SIC: 2834 NAIC: 325412)Pfizer is a research‐based, global pharmaceutical company that discovers, develops, manufactures and markets medicines for humans and animals as well as consumer healthcare products. The products include Norvasc, for the treatment of hypertension and angina, Zyrtec, an anti‐allergy medicine ...
openaire +2 more sources
AbstractPharmaceuticals (MIC: 9.1 SIC: 2834 NAIC: 325412)Pfizer is a research‐based, global pharmaceutical company that discovers, develops, manufactures and markets medicines for humans and animals as well as consumer healthcare products. The products include Norvasc, for the treatment of hypertension and angina, Zyrtec, an anti‐allergy medicine ...
openaire +2 more sources
2018
Pfizer has grown by megamergers and acquisitions. In the year 2000, Pfizer acquired Warner–Lambert. This $90-billion merger deal resulted in the creation of the second largest pharmaceutical company in the world. The deal ended the 3-month hostile battle to acquire Warner–Lambert. On merger completion, Pfizer shareholders owned approximately 61% of the
openaire +1 more source
Pfizer has grown by megamergers and acquisitions. In the year 2000, Pfizer acquired Warner–Lambert. This $90-billion merger deal resulted in the creation of the second largest pharmaceutical company in the world. The deal ended the 3-month hostile battle to acquire Warner–Lambert. On merger completion, Pfizer shareholders owned approximately 61% of the
openaire +1 more source
Pfizer-BioNTech and Sinopharm: A Comparative Study on Post-Vaccination Antibody Titers
Vaccines, 2021Rami Alqassieh +2 more
exaly
Current opinion in investigational drugs (London, England : 2000), 2003
Avasimibe (also known as CI-1011 or PD-148515) is a selective acyl-coenzyme A:cholesterol O-acyltransferase (ACAT) inhibitory lipid-regulating agent under development by Pfizer (formerly Parke-Davis) for the potential treatment of hyperlipidemia and atherosclerosis. The compound is currently undergoing phase III clinical trials [371470].
John R, Burnett, Murray W, Huff
openaire +1 more source
Avasimibe (also known as CI-1011 or PD-148515) is a selective acyl-coenzyme A:cholesterol O-acyltransferase (ACAT) inhibitory lipid-regulating agent under development by Pfizer (formerly Parke-Davis) for the potential treatment of hyperlipidemia and atherosclerosis. The compound is currently undergoing phase III clinical trials [371470].
John R, Burnett, Murray W, Huff
openaire +1 more source